Structure via PubChem · Public domain (PubChem)
asymbescaline
Sign in to saveAlso known as ASB, 3,4-diethoxy-5-methoxyphenethylamine, 2-(3,4-diethoxy-5-methoxyphenyl)ethan-1-amine
Asymbescaline (ASB), also known as 3,4-diethoxy-5-methoxyphenethylamine, is a psychedelic drug of the phenethylamine and scaline families related to mescaline. It is the analogue of mescaline in which the methoxy groups at the 3 and 4 positions have been replaced with ethoxy groups.
Chemical data
- Formula
- C13H21NO3
- Molecular weight
- 239.31 g/mol
- IUPAC name
- 2-(3,4-diethoxy-5-methoxyphenyl)ethanamine
- SMILES
- CCOC1=CC(=CC(=C1OCC)OC)CCN
- InChIKey
- VFOAVFQWZYUFQZ-UHFFFAOYSA-N
- XLogP
- 1.5
- Polar surface area
- 53.7 Ų
- H-bond donors
- 1
- H-bond acceptors
- 4
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Molecule type
- Small molecule
via ChEMBL · EBI
Wikidata facts
- Subclass of
- phenethylamine
- Has part
- hydrogen
- Mass
- 239.152144
Show 5 more facts
- chemical formula
- C₁₃H₂₁NO₃
- canonical SMILES
- CCOC1=CC(=CC(=C1OCC)OC)CCN
- discoverer or inventor
- Alexander Shulgin
- subject has role
- psychedelic drug
- described by source
- Phenethylamines I Have Known And Loved
Sources (2)
via Wikidata · CC0
~2 min read
Encyclopedic overview
12 sectionsContents
- Use and effects
- Interactions
- Chemistry
- Synthesis
- Analogues
- History
- Society and culture
- Legal status
- Canada
- See also
- References
- External links
Asymbescaline (ASB), also known as 3,4-diethoxy-5-methoxyphenethylamine, is a psychedelic drug of the phenethylamine and scaline families related to mescaline. It is the analogue of mescaline in which the methoxy groups at the 3 and 4 positions have been replaced with ethoxy groups.
==Use and effects== In his book PiHKAL (Phenethylamines I Have Known and Loved) and other publications, Alexander Shulgin lists asymbescaline's dose as 200 to 280mg orally and its duration as 10 to 15hours. The time to peak was approximately 2hours.
Excerpted from Wikipedia’s “asymbescaline” article, available under the CC BY-SA 4.0 licence.